ArTS Archivio della ricerca di Trieste

MUSTACCHI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.860
NA - Nord America 5.257
AS - Asia 2.425
SA - Sud America 253
AF - Africa 125
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 6
Totale 30.947
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 20.130
US - Stati Uniti d'America 5.213
SG - Singapore 980
CN - Cina 502
FR - Francia 465
UA - Ucraina 396
SE - Svezia 324
GB - Regno Unito 242
VN - Vietnam 234
HK - Hong Kong 231
DE - Germania 223
NL - Olanda 208
BR - Brasile 189
KR - Corea 162
CH - Svizzera 155
FI - Finlandia 139
PL - Polonia 125
RU - Federazione Russa 102
TR - Turchia 76
MA - Marocco 70
IE - Irlanda 66
IN - India 64
BG - Bulgaria 63
RO - Romania 41
ES - Italia 33
AL - Albania 29
BE - Belgio 24
AR - Argentina 23
CA - Canada 22
JP - Giappone 21
EU - Europa 20
BD - Bangladesh 19
IQ - Iraq 19
CI - Costa d'Avorio 17
IR - Iran 16
GR - Grecia 14
PT - Portogallo 14
MY - Malesia 13
DK - Danimarca 12
MX - Messico 12
AT - Austria 11
JO - Giordania 11
PK - Pakistan 11
SA - Arabia Saudita 10
ZA - Sudafrica 10
CL - Cile 9
CZ - Repubblica Ceca 9
IL - Israele 9
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
KE - Kenya 7
AE - Emirati Arabi Uniti 6
SI - Slovenia 6
SM - San Marino 6
UZ - Uzbekistan 6
VE - Venezuela 6
HR - Croazia 5
PY - Paraguay 5
TH - Thailandia 5
TN - Tunisia 5
AU - Australia 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PH - Filippine 4
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
JM - Giamaica 3
MD - Moldavia 3
OM - Oman 3
AO - Angola 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CF - Repubblica Centrafricana 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
LB - Libano 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
Totale 30.942
Salva come PNG Salva come JPEG
Città #
Rome 1.155
Milan 1.091
Singapore 594
Woodbridge 538
Ann Arbor 424
Fairfield 379
Ashburn 378
Jacksonville 340
Houston 330
Chandler 320
Naples 320
San Jose 261
Hong Kong 227
Florence 225
Wilmington 218
Turin 203
Bologna 200
Seattle 184
Hefei 176
Seoul 161
Trieste 159
Padova 158
Palermo 157
Napoli 138
Cambridge 132
Princeton 118
Bari 113
Boardman 113
Torino 109
Genoa 100
Catania 96
Dallas 94
Brescia 91
Santa Clara 87
Ho Chi Minh City 83
Beijing 80
Chicago 76
Cagliari 75
Verona 72
Perugia 63
Casablanca 62
Columbus 61
Dublin 61
Bergamo 60
Sofia 59
Zgierz 59
Izmir 57
Lauterbourg 54
Hanoi 46
Pescara 45
Monza 44
Moscow 44
Caserta 43
Messina 42
Buffalo 41
Genova 41
Mountain View 41
Udine 41
Amsterdam 40
Como 40
Treviso 37
Venezia 37
Dearborn 36
Reggio Calabria 36
Vicenza 34
Pisa 33
Modena 32
Sassari 32
Lucca 31
London 30
Los Angeles 30
San Diego 30
The Dalles 30
Ancona 29
Taranto 29
Latina 28
Venice 28
Catanzaro 27
Frankfurt am Main 27
Prato 27
Reggio Nell'emilia 26
Parma 25
Livorno 24
Helsinki 23
Pavia 23
Salerno 23
Bremen 22
Foggia 22
Redwood City 22
Siena 22
Novara 21
São Paulo 21
Trento 21
Mumbai 20
Düsseldorf 19
Ferrara 19
Abbiategrasso 18
Legnano 18
Mestre 18
New York 18
Totale 11.867
Salva come PNG Salva come JPEG
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.794
Advances in systemic therapy for metastatic breast cancer: future perspectives 409
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. 274
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 253
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 239
Breast cancer in elderly women: a different reality? Results from the NORA Study 218
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 217
Adjuvant systemic treatment of early breast cancer: The NORA study. 213
Role of lifestyles in breast cancer risk: a retrospective analysis of Trieste's female population 210
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial 207
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. 199
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. 195
Early detection of breast cancer recurrences through periodic follow up - Is it useless? 190
Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials 188
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study. 184
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study 181
Psychological Response to Cancer: Role of 5-HTTLPR Genetic Polymorphism of Serotonin Transporter 180
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 178
Gene expression profiling in breast cancer: A clinical perspective 169
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study 168
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database 166
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancerdeath: meta-analysis of individual patient data for 10,801 women in 17 randomised trials 165
Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer 164
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 7 years of the 1st GROCTA Trial. 160
A multicentre, double blind, randomised trial comparing ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 158
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study 157
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy. 156
Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast cancer Patients: Results of an Italian Cooperative Study 155
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs 154
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study. 152
Cancro del fegato: possibilità di diagnosi precoce 152
Changes in adjuvant treatment of early breast cancer in Italy between 2000 and 2008. The NEMESI study versus the NORA study. 150
Carcinoma dell’ovaio 149
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study. 147
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 145
ITALIAN BREAST CANCER ADJUVANT CHEMO-HORMONE THERAPY COOPERATIVE GROUP TRIALS 144
Effectiveness of magnetotheraphy in resolution of some early complications of the mastectomy operation. 141
Gli antidoti in Oncologia medica: efficacia, costo e beneficio 139
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 8 years of the first GROCTA (Italian Cooperative Group for Adjuvant Chemo-Hormonal Therapy of Breast cancer)Trial. 133
Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting. J Clin Oncol 30, 2012 (suppl; abstr 586) 132
La metanalisi di Oxford del 2000: riflessioni e commenti 131
Modulating effect of Lonidamine on Response to Doxorubicin in Metastatic Breast cancer patients: Results from a Multicenter Prospective Randomized Trial. 130
Molecular targets of cancer chemotherapy 129
The combination of Metoclopramide, Methylprednisolone and Ondansetron against antiblastic - delayed emesis: a randomised Phase II study. 128
Un programme de réhabilitation chez la femme mastectomisée 127
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 127
Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17-beta-estradiol and progesterone throughout one entire menstrual cycle 126
Extragonadal Germ Cell Tumor: a Clinical Stdy. 121
Prevention of chemotherapy-induced early menopause in early breast cancer patients. A phase III multicenter study of GIM Group 119
Il Carcinoma del Fegato: Realtà e Prospettive Epidemiologia 116
Observer variations in mammary thermography: results of a teaching file test carried out in four different centers 110
La communication du diagnostic de cancer 110
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 109
Tamoxifen or Surgery plus Tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial 107
Prolonged Tamoxifen Treatment of Early Breast Cancer: The experience of the Italian Cooperative Group for Chemo-Hormonal Therapy of Early Breast Cancer. 105
Effect of menstrual status on response to adjuvant chemotherapy and /or endocrine therapy. 98
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter “GRETA” trial. 97
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study 96
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. 96
Role of erythropoietin in the oncology patient: critical review of the literature 94
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 81
Totale 31.242
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021643 0 0 0 0 0 0 0 0 0 253 185 205
2021/20221.895 112 142 124 154 121 95 101 110 211 171 169 385
2022/20234.469 323 320 351 347 367 472 293 369 427 284 451 465
2023/20243.525 447 401 315 332 273 185 351 326 76 289 283 247
2024/20252.813 274 286 485 246 235 208 167 153 304 171 156 128
2025/20262.951 255 248 242 315 239 313 367 140 385 447 0 0
Totale 31.242